Key Laboratory of Smart Drug Delivery (Fudan University), Ministry of Education, Department of Pharmaceutics Sciences, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai 201203, China ...

Treatment should be stopped if nonarteritic anterior ischemic optic neuropathy, which can cause vision loss, is diagnosed.

Peptides are hot! Check the label of a skin care product and you are likely to come across a peptide. Read one of the numerous articles about Ozempic and you will discover that the active ingredient, ...

The group outlined the mechanism of action and effectiveness of the experimental drug known as JM2, revealing its potential as a peptide therapy to target cancer cells that can renew and regrow ...

Veru's Phase 2b study shows enobosarm combined with semaglutide improves safety, reduces gastrointestinal issues, and promotes fat loss while preserving lean mass. There is a potential risk that ...

Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY ...

What is it? A medication called semaglutide, which is sold under different brand names, including Ozempic, approved in 2017 for treating type 2 diabetes, and Wegovy, approved just last year for ...

Ozempic (semaglutide) belongs to a group of medications called GLP-1 receptor agonists that help treat type 2 diabetes. This medication is a once-weekly injection that helps regulate blood sugar ...

Department of Chemistry, International Institute for Nanotechnology, Northwestern University, Evanston, Illinois 60208, United States Department of Chemistry and Chemical & Biomedical Engineering, ...

Patients from New York and New Jersey have claimed that they suffered non-arteritic anterior ischemic optic neuropathy after taking drugs containing semaglutide — the active ingredient in ...

The allegations come amid several recent studies showing a link between vision complications and people taking drugs containing semaglutide, the active ingredient in Ozempic, Wegovy and Rybelsus ...

Patients with obesity who took semaglutide had lower risk for fractures vs. those who had sleeve gastrectomy. More research is needed to determine the relationship between semaglutide and bone health.